Summary Box: Shares of electric car maker Tesla gain more than 40 percent on 1st trading day
By admin
Summary Box: Tesla shares soar in 1st-day trading
THE STOCK: Shares of Tesla Motors Inc. soared in their first day of trading Tuesday, gaining $6.89, or 40.5 percent, to close at $23.89. That marked the second-biggest first-day gain among initial public offerings this year.
THE OFFERING: Tesla’s initial public offering raised $226.1 million after selling 13.3 million … .
URL: http://blog.taragana.com/index.php/archive/summary-box-shares-of-electric-car-maker-tesla-gain-more-than-40-percent-on-1st-trading-day/
Related Post
- StemCells, Inc., Hoping for as Much as $40 Million from California Stem Cell Agency - May 13th, 2012
- $2.4 Million for State Stem Cell Lawyers: Too Much or Not Enough? - May 13th, 2012
- Biotech Biz Alert: California Stem Cell Agency Altering Loan Policies - May 13th, 2012
- Advisor to CIRM Nominated to Board of CIRM Grant Recipient Expecting $5 Million from Agency - May 13th, 2012
- Kudos to CIRM: Stem Cell Agency Sticks with Full Financial Disclosure - May 6th, 2012
- Researcher Alert: First Look at Proposed Rules for California's Stem Cell Bank - May 6th, 2012
- ACT and CIRM Together on Eye Research Webinar - May 6th, 2012
- MissionIR News - VistaGen Therapeutics Awarded U.S. Stem Cell Technology Patent Covering Methods Used to Test Drug ... - April 29th, 2012
- Actress Shilpa Shetty to store her baby's stem cells - April 29th, 2012
- Cymbalta or Stem Cells? - April 29th, 2012
- IBN DISCOVERS HUMAN - 2 - April 29th, 2012
- From embryonic stem cells, a sperm replacement and easier path to genetic modification - April 29th, 2012
- Neural stem cells: clinging together and letting go - April 29th, 2012
- Hardly any genes are activated in embryonic stem cells - April 29th, 2012
- Stem cells repairing hearts - April 29th, 2012
- ASH Agenda for Hematology Research identifies most promising areas for scientific discovery - April 29th, 2012
- Stanford study points to potential treatment for stroke - April 29th, 2012
- Stem cell researchers map new knowledge about insulin production - April 29th, 2012
- New embryonic stem cell line will aid research on nerve condition - April 29th, 2012
- Inspired by insects - April 29th, 2012
- New Microdevice Enables Culture of Rare Circulating Tumor Cells from Blood - April 29th, 2012
- Scientists develop new technique that could improve heart attack prediction - April 29th, 2012
- Bile - not Acid - is Bad Guy in Triggering Precancerous Condition Associated with Reflux Disease - April 29th, 2012
- RANK protein promotes the initiation, progression and metastasis of human breast cancer - April 29th, 2012
- New stem cell found in the brain - April 29th, 2012
- 2 distinguishable gene groups detected: 1 'normal' and 1 problematic - April 29th, 2012
- VistaGen Licenses Breakthrough Stem Cell Culture Technology to Speed Development of Drug Screening and Cell Therapy ... - April 29th, 2012
- How stem cell therapy can keep the immune system under control - April 29th, 2012
- Stemlogix Selects Butler Schein Animal Health to Distribute Versatile In-Clinic Stem Cell Therapy System to ... - April 29th, 2012
- Stem cell division to evaluate clinical trials - April 29th, 2012
- Raiders' Rolando McClain: Stem-cell therapy worked well - April 29th, 2012
- Texas board approves controversial stem-cell therapy - April 29th, 2012
- Precision StemCell Brings Advanced Image-Guided Stem Cell Therapy to U.S. - April 29th, 2012
- California Stem Cell Agency Wants to Weaken Financial Disclosure for Execs and Board - April 29th, 2012
- Text of CIRM Response on the Weakening of Financial Disclosure Requirements - April 29th, 2012
- California Stem Cell Agency Launches $30 Million Plan to Lure Industry - April 22nd, 2012
- Determining a stem cell's fate - April 15th, 2012
- On the move - April 15th, 2012
- CEO of Biotime's Comments on Stem Cell Agency and Development of Therapies - April 15th, 2012
- California Stem Cell Agency Cited for Improvements in Transparency - April 15th, 2012
Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research



June 30th, 2010